The finger loop of the SRA domain in the E3 ligase UHRF1 is a regulator of ubiquitin targeting and is required for the maintenance of DNA methylation.

DNA methylation DNA-binding protein E3 ubiquitin ligase SRA domain allosteric regulation epigenetics molecular dynamics string method in collective variables ubiquitin-like with PHD and RING finger domains 1 (UHRF1)

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
25 10 2019
Historique:
received: 11 07 2019
revised: 29 08 2019
pubmed: 5 9 2019
medline: 3 6 2020
entrez: 5 9 2019
Statut: ppublish

Résumé

The Su(var)3-9, enhancer of zeste, and trithorax (SET) and really interesting new gene (RING) finger-associated (SRA) protein domain is conserved across bacteria and eukaryota and coordinates extrahelical or "flipped" DNA bases. A functional SRA domain is required for ubiquitin-like with PHD and RING finger domains 1 (UHRF1) E3 ubiquitin ligase activity toward histone H3, a mechanism for recruiting the DNA methylation maintenance enzyme DNA methyltransferase 1 (DNMT1). The SRA domain supports UHRF1 oncogenic activity in colon cancer cells, highlighting that UHRF1 SRA antagonism could be a cancer therapeutic strategy. Here we used molecular dynamics simulations, DNA binding assays,

Identifiants

pubmed: 31481468
pii: S0021-9258(20)30334-3
doi: 10.1074/jbc.RA119.010160
pmc: PMC6816099
doi:

Substances chimiques

CCAAT-Enhancer-Binding Proteins 0
Phosphates 0
Ubiquitin 0
DNA 9007-49-2
UHRF1 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27

Banques de données

PDB
['2ZKD', '3CLZ', '3Q0C', '4NJ5', '4QEN', '4PW6']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

15724-15732

Subventions

Organisme : NCI NIH HHS
ID : F99 CA245821
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM124736
Pays : United States

Informations de copyright

© 2019 Vaughan et al.

Références

Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):8775-8780
pubmed: 30104358
Nucleic Acids Res. 2018 May 18;46(9):4405-4416
pubmed: 29506131
J Chem Theory Comput. 2008 Mar;4(3):435-47
pubmed: 26620784
J Chem Phys. 2016 Oct 21;145(15):154113
pubmed: 27782467
Nature. 2008 Oct 9;455(7214):818-21
pubmed: 18772891
Cancer Cell. 2019 Apr 15;35(4):633-648.e7
pubmed: 30956060
Mol Cell. 2014 Aug 7;55(3):495-504
pubmed: 25018018
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Biosci Rep. 2018 Dec 18;38(6):
pubmed: 30352833
Cell Res. 2011 Dec;21(12):1723-39
pubmed: 22064703
Biophys Chem. 2013 Jan;171:38-45
pubmed: 23245651
Sci Rep. 2016 Feb 04;6:20161
pubmed: 26841909
Cancer Cell. 2014 Feb 10;25(2):196-209
pubmed: 24486181
Mol Cell. 2017 Oct 19;68(2):350-360.e7
pubmed: 29053958
Nucleic Acids Res. 2018 Nov 16;46(20):e123
pubmed: 30085201
Elife. 2016 Sep 06;5:
pubmed: 27595565
Nucleic Acids Res. 2018 Jan 4;46(D1):D493-D496
pubmed: 29040681
Genes Dev. 2011 Jan 15;25(2):137-52
pubmed: 21245167
Oncotarget. 2018 May 25;9(40):26243-26258
pubmed: 29899856
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Nature. 2018 Feb 15;554(7692):387-391
pubmed: 29414941
Philos Trans A Math Phys Eng Sci. 2004 Jul 15;362(1820):1439-60
pubmed: 15306460
Nucleic Acids Res. 2016 Jul 8;44(W1):W232-5
pubmed: 27084950
Nat Chem Biol. 2012 Feb 12;8(4):328-30
pubmed: 22327402
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8793-E8802
pubmed: 30150382
Nucleic Acids Res. 2012 Aug;40(15):7552-62
pubmed: 22570415
Mol Cell. 2014 Jun 5;54(5):879-86
pubmed: 24813944
Science. 2012 Feb 10;335(6069):709-12
pubmed: 22323818
Nature. 2008 Oct 9;455(7214):826-9
pubmed: 18772888
Oncol Rep. 2012 Dec;28(6):1997-2002
pubmed: 23023523
Cell. 1994 Jan 28;76(2):357-69
pubmed: 8293469
J Chem Phys. 2006 Jul 14;125(2):24106
pubmed: 16848576
Science. 2007 Sep 21;317(5845):1760-4
pubmed: 17673620
Oncotarget. 2017 Apr 24;8(31):51946-51962
pubmed: 28881702
Biophys Chem. 2014 Mar-Apr;187-188:14-22
pubmed: 24469333
Nature. 2008 Oct 9;455(7214):822-5
pubmed: 18772889

Auteurs

Robert M Vaughan (RM)

Center for Epigenetics, Van Andel Research Institute, Grand Rapids, Michigan 49503.

Scott B Rothbart (SB)

Center for Epigenetics, Van Andel Research Institute, Grand Rapids, Michigan 49503 scott.rothbart@vai.org.

Bradley M Dickson (BM)

Center for Epigenetics, Van Andel Research Institute, Grand Rapids, Michigan 49503 bradley.dickson@vai.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH